4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000107
EVP, Chief Technical Ops. Off. sold 1,767 shares at $480.95 ($849,839)
- EVP, Chief Technical Ops. Off. gave up 1,656 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Atkinson Edward Morrow III · EVP, Chief Technical Ops. Off.
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-24 | Shares withheld for taxes : show line 1 in the form 10b5-1 | −1,656 | $483.28 | $800,312 | 26,251 | D |
| 2025-02-25 | Sale : show line 2 in the form 10b5-1 | −1,767 | $480.95 | $849,839 | 24,484 | D |
| Open-market sales · 1,767 sh · avg $480.95 · $849,839 | ||||||
Loading xslF345X05/wk-form4_1740604171.xml…